BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 32603719)

  • 1. Clinically meaningful change in itch intensity scores: An evaluation in patients with chronic kidney disease-associated pruritus.
    Vernon M; Ständer S; Munera C; Spencer RH; Menzaghi F
    J Am Acad Dermatol; 2021 Apr; 84(4):1132-1134. PubMed ID: 32603719
    [No Abstract]   [Full Text] [Related]  

  • 2. Difelikefalin (Korsuva) for chronic kidney disease-associated pruritus.
    Med Lett Drugs Ther; 2022 Feb; 64(1643):18-19. PubMed ID: 35134047
    [No Abstract]   [Full Text] [Related]  

  • 3. Difelikefalin improves itch-related sleep disruption in patients undergoing haemodialysis.
    Weiner DE; Schaufler T; McCafferty K; Kalantar-Zadeh K; Germain M; Ruessmann D; Morin I; Menzaghi F; Wen W; Ständer S
    Nephrol Dial Transplant; 2024 Jun; 39(7):1125-1137. PubMed ID: 37968132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with Pruritus.
    Fishbane S; Jamal A; Munera C; Wen W; Menzaghi F;
    N Engl J Med; 2020 Jan; 382(3):222-232. PubMed ID: 31702883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, placebo-controlled, double-blind trial of ondansetron in renal itch.
    Murphy M; Reaich D; Pai P; Finn P; Carmichael AJ
    Br J Dermatol; 2003 Feb; 148(2):314-7. PubMed ID: 12588385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Difelikefalin on the Health-Related Quality of Life of Haemodialysis Patients with Moderate-To-Severe Chronic Kidney Disease-Associated Pruritus: A Single-Arm Intervention Trial.
    Fotheringham J; Guest J; Latus J; Lerma E; Morin I; Schaufler T; Soro M; Ständer S; Zeig S
    Patient; 2024 Mar; 17(2):203-213. PubMed ID: 38196014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pruritus in systemic diseases : Common and rare etiologies].
    Kremer AE; Mettang T
    Internist (Berl); 2019 Aug; 60(8):814-820. PubMed ID: 31243493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kappa-opioid system in uremic pruritus: multicenter, randomized, double-blind, placebo-controlled clinical studies.
    Wikström B; Gellert R; Ladefoged SD; Danda Y; Akai M; Ide K; Ogasawara M; Kawashima Y; Ueno K; Mori A; Ueno Y
    J Am Soc Nephrol; 2005 Dec; 16(12):3742-7. PubMed ID: 16251241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gabapentin in the treatment of uremic itch: an index case and a pilot evaluation.
    Manenti L; Vaglio A; Costantino E; Danisi D; Oliva B; Pini S; Prati E; Testori A
    J Nephrol; 2005; 18(1):86-91. PubMed ID: 15772928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Difelikefalin in Black/African American Hemodialysis Patients with Moderate-to-Severe Pruritus: Post hoc Analysis of KALM-1 and KALM-2.
    Fishbane S; Clegg DJ; Lerma EV; Rastogi A; Budden J; Morin I; Wen W; Menzaghi F; Topf J
    Am J Nephrol; 2024; 55(3):329-333. PubMed ID: 38253036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-carnitine does not alleviate uremic pruritus in hemodialysis patients.
    Mettang T; Thomas S; Kuhlmann U
    Nephron; 1997; 75(3):372. PubMed ID: 9069470
    [No Abstract]   [Full Text] [Related]  

  • 12. Topical capsaicin therapy for uremic pruritus in patients on hemodialysis.
    Makhlough A; Ala S; Haj-Heydari Z; Kashi Z; Bari A
    Iran J Kidney Dis; 2010 Apr; 4(2):137-40. PubMed ID: 20404425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase 2 study of oral difelikefalin in subjects with chronic kidney disease and moderate-to-severe pruritus.
    Yosipovitch G; Awad A; Spencer RH; Munera C; Menzaghi F
    J Am Acad Dermatol; 2023 Aug; 89(2):261-268. PubMed ID: 37059302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A common cause of pruritus in dialysis patients.
    Jenkins P
    Am J Kidney Dis; 2008 Feb; 51(2):345; author reply 345-6. PubMed ID: 18215714
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pruritus in systemic diseases : Common and rare etiologies].
    Kremer AE; Mettang T
    Hautarzt; 2016 Aug; 67(8):606-14. PubMed ID: 27376752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis.
    Yosipovitch G; Goon A; Wee J; Chan YH; Goh CL
    Br J Dermatol; 2000 Nov; 143(5):969-73. PubMed ID: 11069504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Difelikefalin: First Approval.
    Deeks ED
    Drugs; 2021 Nov; 81(16):1937-1944. PubMed ID: 34674115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Uremic Pruritus: A Systematic Review.
    Simonsen E; Komenda P; Lerner B; Askin N; Bohm C; Shaw J; Tangri N; Rigatto C
    Am J Kidney Dis; 2017 Nov; 70(5):638-655. PubMed ID: 28720208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic kidney disease-associated pruritus in patients undergoing hemodialysis: Xerosis and topical therapy.
    Krismi A; Danarti R; Setiabudi IIDPP; Wirohadidjojo YW
    Hemodial Int; 2023 Apr; 27(2):91-104. PubMed ID: 36811513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of gabapentin and hydroxyzine in the treatment of pruritus in patients on dialysis.
    Mohammadi Kebar S; Sharghi A; Ghorghani M; Hoseininia S
    Clin Exp Dermatol; 2020 Oct; 45(7):866-871. PubMed ID: 32363638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.